The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
it doesn't nor T helper cell responses which tend to be broader and and are of value and that they do offer that sort of broader immunity where even though there have been mutations in the um in the receptor binding domain or the n-terminal domain that you you still would get some evidence of immunity that's why T helper cell responses are so critical here
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.